FLUAD QUADRIVALENT

STN: 125510 
Proper Name: Influenza Vaccine, Adjuvanted
Tradename: FLUAD QUADRIVALENT
Manufacturer: Seqirus, Inc.
Indications:

• For active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine

Product Information

• Package Insert - FLUAD QUADRIVALENT

Supporting Documents

• June 30, 2023 Approval Letter - FLUAD QUADRIVALENT
• February 24, 2023 Approval Letter - FLUAD QUADRIVALENT
• July 1, 2022 Approval Letter - FLUAD QUADRIVALENT
• July 2, 2021 Approval Letter - FLUAD
• Statistical Review - FLUAD and FLUAD Quadrivalent
• Clinical Review - FLUAD and FLUAD Quadrivalent
• December 4, 2020 Approval Letter - FLUAD QUADRIVALENT
• October 28, 2020 Approval Letter - Fluad and Fluad Quadrivalent
• July 2, 2020 Approval Letter Fluad and Fluad Quadrivalent
• February 21, 2020 Approval Letter - FLUAD QUADRIVALENT
• February 20, 2020 Clinical Review - FLUAD QUADRIVALENT
• Statistical Review - FLUAD QUADRIVALENT